Careers  |   Log In  |   Register  |   Welcome Center  |   Follow Us  Facebook  Twitter Google Plus
 
Course List


  • CME Information

Title:

Individualized Management of Patients with T2DM via Combination Therapy:
What You Need to Know

  1. Interview #1 - Recent Advances in Insulin and Incretin Therapy in Type 2 Diabetes
  2. Interview #2 - Individualizing Treatment with Insulin and Incretin Combination Therapy

Provider Statement

This continuing medical education activity is provided by Vindico Medical Education. .

Support Statement

This activity is supported by an educational grant from Novo Nordisk, Inc.

Activity Chair:

Scott V. Joy, MD, MBA, FACP
The Colorado Health Foundation
Medical Director
Uptown Primary Care
Presbyterian/St. Luke's Medical Center
Denver, CO
Professor of Clinical Practice
University of Colorado School of Medicine
Aurora, CO

Disclosures:

Consulting Fee: AstraZeneca, Boehringer-Ingelheim, Eli Lilly, Exact Sciences, Janssen, Novo Nordisk

Faculty:

Jill Ellis, PA-C
Masters in Physician Assistant Studies
Assistant Professor
Physician Assistant
Grand Valley State University
Grand Rapids, MI

Disclosures:

No relevant financial relationships to disclose.

External Reviewer:

Linda Giarraputo, PA
No relevant financial relationships to disclose.

Vindico Medical Education staff report the following relationship(s):

No relevant financial relationships to disclose.

Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.

Disclosures

In accordance with the Accreditation Council for Continuing Education's Standards for Commercial Support, all planners, teachers, authors, and reviewers involved in the development of CME content are required to disclose to the accredited provider their relevant financial relationships. Relevant financial relationships will be disclosed to the activity audience prior to viewing content.

Accreditation

Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation

This program has been reviewed and is approved for a maximum of 0.50 hours of AAPA Category I CME credit by the Physician Assistant Review Panel (0.25 hours per video).

PAs should claim only those hours actually spent participating in the CME activity.

This enduring material is approved for 1 year from the date of original release, July 19, 2016 to July 18, 2017.

How To Participate in this Activity and Obtain CME Credit

To participate in this CME activity per video, you must read the objectives, answer the pretest questions, watch the presentations, complete the CME posttests, and then fill in the evaluations. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 2 out of 3 of the posttest questions correctly per video. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AAPA Category I CME Certificate.

Overview

Type 2 diabetes mellitus is a complex, progressive disease that necessitates comprehensive and individualized patient treatment strategies. Despite the availability of many effective treatments, many patients fail to achieve satisfactory glycemic control. Clinical inertia and patient apprehension often play a role in delaying timely treatment intensification of injectable therapies, particularly in primary care. This CME activity aims to provide physician assistants with tools to overcome provider- and patient-related barriers to initiating or intensifying insulin- and/or incretin-based therapies.

The faculty will discuss recent clinical evidence, best practices, and guideline recommendations regarding the optimal use, safety, and efficacy of the various agents in the management of type 2 diabetes. Through case discussions, participants will be provided with practical strategies for utilizing combination therapy, individualizing treatment based on patient characteristics and priorities, as well as disease factors.

Target Audience

The intended audience for the activity is physician assistants and other health care professionals involved in the management of patients with diabetes.

Learning Objectives

Upon successful completion of the activity, participants should be better able to:

  • Implement treatment strategies that reflect recent advances in insulin and incretin-based treatment strategies for the management of T2DM.
  • Examine effective strategies to overcome barriers that impede the use of insulin and/or incretin-based therapies for the treatment of T2DM.
  • Review recent advances in combination treatment strategies for patients with T2DM and identify patients who may benefit from such regimens.
  • Employ safe and effective combination insulin/incretin-based therapy in appropriate patients with T2DM.

Unlabeled and Investigational Usage

The audience is advised that this continuing medical education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.

Copyright Statement

Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2016 Vindico Medical Education. All rights reserved.

No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.

Educational Tools:

For downloadable handouts, patient education tools, and online resources for your clinical practice provided by Vindico Medical Education, please visit: www.VindicoCME.com/EducationalTools.

CME Questions?

Contact us at cme@vindicocme.com or 856-994-9400, ext. 504.